Clinical Trials Directory

Trials / Conditions / Lymphoblastic Leukemia in Children

Lymphoblastic Leukemia in Children

7 registered clinical trials studyying Lymphoblastic Leukemia in Children — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
NCT06810583
St. Jude Children's Research HospitalPhase 1
RecruitingTreatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
NCT06099366
Hee Young JuPhase 2
UnknownDual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage
NCT05429905
KK Women's and Children's HospitalPhase 1 / Phase 2
RecruitingCD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lym
NCT05648019
KK Women's and Children's HospitalPhase 2
RecruitingCARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic
NCT05043571
National University Hospital, SingaporePhase 1
RecruitingALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
NCT05038696
National University Hospital, SingaporePhase 1
CompletedAssociation Between Mitochondrial DNA Content and Risk of Acute Leukemia
NCT03595969
Air Force Military Medical University, China—